Cargando…

Research Note: Evaluation of deoxycholic acid for antihistomonal activity

Deoxycholic acid (DCA) is a naturally occurring secondary bile acid that originates from intestinal bacterial metabolic conversion of cholate, a primary bile acid. Deoxycholic acid was shown to have antihistomonal properties in vitro, leading to our hypothesis that DCA inclusion within the feed migh...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, L.C., Latorre, J.D., Rochell, S.J., Sun, X., Tellez, G., Fuller, A.L., Hargis, B.M., Vuong, C.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597822/
https://www.ncbi.nlm.nih.gov/pubmed/32616242
http://dx.doi.org/10.1016/j.psj.2020.03.049
_version_ 1783602449726046208
author Beer, L.C.
Latorre, J.D.
Rochell, S.J.
Sun, X.
Tellez, G.
Fuller, A.L.
Hargis, B.M.
Vuong, C.N.
author_facet Beer, L.C.
Latorre, J.D.
Rochell, S.J.
Sun, X.
Tellez, G.
Fuller, A.L.
Hargis, B.M.
Vuong, C.N.
author_sort Beer, L.C.
collection PubMed
description Deoxycholic acid (DCA) is a naturally occurring secondary bile acid that originates from intestinal bacterial metabolic conversion of cholate, a primary bile acid. Deoxycholic acid was shown to have antihistomonal properties in vitro, leading to our hypothesis that DCA inclusion within the feed might prevent histomoniasis. Selected dietary concentrations of DCA were evaluated for effects on body weight gain (BWG), lesions, and mortality of turkeys challenged with wild-type Histomonas meleagridis (WTH). Treatments consisted of non-challenged control (NC; basal diet), 0.25% DCA diet + challenge, 0.5% DCA diet + challenge, 1% DCA diet + challenge, and a positive-challenged control (PC; basal diet). All groups were fed a basal starter diet until day 7, at which time DCA diets were administered to the respective groups. On day 14, 2 × 10(5) WTH cells/turkey were intracloacally administered. H. meleagridis-related lesions were evaluated on day 13 post-challenge. Pre-challenge day 0 to 14 BWG was higher (P ≤ 0.05) in the 0.25% DCA group than in the 1% DCA group. There were no significant differences in pre-challenge day 0 to 14 BWG between any of the other groups. No significant differences in mortalities from histomoniasis occurred in the DCA groups as compared to the PC group. No H. meleagridis lesions or mortalities were observed at any time in the NC group. Presence of H. meleagridis-related liver lesions was higher (P ≤ 0.05) in the 0.5% DCA group as compared to the PC group. Using the same controls and experimental timeline, an additional group was included to evaluate a biliogenic diet formulated with 20% whole egg powder to encourage endogenous bile acid production. The biliogenic diet had no statistical impact on pre-challenge day 0 to 14 BWG, but did not reduce H. meleagridis-related mortalities or lesions after the challenge. Taken together, these data suggest that DCA inclusion within the feed at these concentrations and under these experimental conditions does not prevent histomoniasis.
format Online
Article
Text
id pubmed-7597822
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75978222020-11-03 Research Note: Evaluation of deoxycholic acid for antihistomonal activity Beer, L.C. Latorre, J.D. Rochell, S.J. Sun, X. Tellez, G. Fuller, A.L. Hargis, B.M. Vuong, C.N. Poult Sci Immunology, Health and Disease Deoxycholic acid (DCA) is a naturally occurring secondary bile acid that originates from intestinal bacterial metabolic conversion of cholate, a primary bile acid. Deoxycholic acid was shown to have antihistomonal properties in vitro, leading to our hypothesis that DCA inclusion within the feed might prevent histomoniasis. Selected dietary concentrations of DCA were evaluated for effects on body weight gain (BWG), lesions, and mortality of turkeys challenged with wild-type Histomonas meleagridis (WTH). Treatments consisted of non-challenged control (NC; basal diet), 0.25% DCA diet + challenge, 0.5% DCA diet + challenge, 1% DCA diet + challenge, and a positive-challenged control (PC; basal diet). All groups were fed a basal starter diet until day 7, at which time DCA diets were administered to the respective groups. On day 14, 2 × 10(5) WTH cells/turkey were intracloacally administered. H. meleagridis-related lesions were evaluated on day 13 post-challenge. Pre-challenge day 0 to 14 BWG was higher (P ≤ 0.05) in the 0.25% DCA group than in the 1% DCA group. There were no significant differences in pre-challenge day 0 to 14 BWG between any of the other groups. No significant differences in mortalities from histomoniasis occurred in the DCA groups as compared to the PC group. No H. meleagridis lesions or mortalities were observed at any time in the NC group. Presence of H. meleagridis-related liver lesions was higher (P ≤ 0.05) in the 0.5% DCA group as compared to the PC group. Using the same controls and experimental timeline, an additional group was included to evaluate a biliogenic diet formulated with 20% whole egg powder to encourage endogenous bile acid production. The biliogenic diet had no statistical impact on pre-challenge day 0 to 14 BWG, but did not reduce H. meleagridis-related mortalities or lesions after the challenge. Taken together, these data suggest that DCA inclusion within the feed at these concentrations and under these experimental conditions does not prevent histomoniasis. Elsevier 2020-04-25 /pmc/articles/PMC7597822/ /pubmed/32616242 http://dx.doi.org/10.1016/j.psj.2020.03.049 Text en © 2020 Published by Elsevier Inc. on behalf of Poultry Science Association Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Immunology, Health and Disease
Beer, L.C.
Latorre, J.D.
Rochell, S.J.
Sun, X.
Tellez, G.
Fuller, A.L.
Hargis, B.M.
Vuong, C.N.
Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title_full Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title_fullStr Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title_full_unstemmed Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title_short Research Note: Evaluation of deoxycholic acid for antihistomonal activity
title_sort research note: evaluation of deoxycholic acid for antihistomonal activity
topic Immunology, Health and Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597822/
https://www.ncbi.nlm.nih.gov/pubmed/32616242
http://dx.doi.org/10.1016/j.psj.2020.03.049
work_keys_str_mv AT beerlc researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT latorrejd researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT rochellsj researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT sunx researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT tellezg researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT fulleral researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT hargisbm researchnoteevaluationofdeoxycholicacidforantihistomonalactivity
AT vuongcn researchnoteevaluationofdeoxycholicacidforantihistomonalactivity